EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors

Yoshiki Fujikawa iD, Shinji Kawabata iD, Kohei Tsujino iD, Hironori Yamada, Hideki Kashiwagi iD, Ryokichi Yagi, Ryo Hiramatsu iD, Naosuke Nonoguchi, Toshihiro Takami, Akinori Sasaki, Naonori Hu iD, Takushi Takata und 3 weitere

Cancer Science · 2024

DOI: 10.1111/cas.16245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Yoshiki Fujikawa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka, Japan. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Spinal Neoplasms, Disease Models, Animal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic spinal tumors are increasingly prevalent due to advancements in cancer treatment, leading to prolonged survival rates. This rising prevalence highlights the need for developing more effective therapeutic approaches to address this malignancy. Boron neutron capture therapy (BNCT) offers a promising solution by delivering targeted doses to tumors while minimizing damage to normal tissue. In this study, we evaluated the efficacy and safety of BNCT as a potential therapeutic option for spine metastases in mouse models induced by A549 human lung adenocarcinoma cells. The animal models were randomly allocated into three groups: untreated ( n = 10), neutron irradiation only ( n = 9), and BNCT ( n = 10). Each mouse was administered 4‐borono‐L‐phenylalanine (250 mg/kg) intravenously, followed by measurement of boron concentrations 2.5 h later. Overall survival, neurological function of the hindlimb, and any adverse events were assessed post irradiation. The tumor‐to‐normal spinal cord and blood boron concentration ratios were 3.6 and 2.9, respectively, with no significant difference observed between the normal and compressed spinal cord tissues. The BNCT group exhibited significantly prolonged survival rates compared with the other groups (vs. untreated, p = 0.0015; vs. neutron‐only, p = 0.0104, log‐rank test). Furthermore, the BNCT group demonstrated preserved neurological function relative to the other groups (vs. untreated, p = 0.0004; vs. neutron‐only, p = 0.0051, multivariate analysis of variance). No adverse events were observed post irradiation. These findings indicate that BNCT holds promise as a novel treatment modality for metastatic spinal tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron Neutron Capture TherapySpinal NeoplasmsDisease Models, AnimalAnimalsMiceHumansLung NeoplasmsPhenylalanineA549 CellsSpinal CordCell Line, TumorBoronFemale

Stichwörter der Autor:innen

4‐borono‐L‐phenylalanineboron neutron capture therapyneoplasm metastasisspinal cord compressionspinal cord neoplasm

Substanzen

PhenylalanineBoron

Autor:innen und Institutionen

  • Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Institute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka, Japan.

ORCID-Profile: Yoshiki Fujikawa, Shinji Kawabata, Kohei Tsujino, Hideki Kashiwagi, Ryo Hiramatsu, Naonori Hu, Hiroki Tanaka, Masahiko Wanibuchi

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Fujikawa, Y., Kawabata, S., Tsujino, K., Yamada, H., Kashiwagi, H., Yagi, R., Hiramatsu, R., Nonoguchi, N., Takami, T., Sasaki, A., Hu, N., Takata, T., Tanaka, H., Suzuki, M., & Wanibuchi, M. (2024). Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors. Cancer Science. https://doi.org/10.1111/cas.16245

Vancouver

Fujikawa Y, Kawabata S, Tsujino K, Yamada H, Kashiwagi H, Yagi R, et al. Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors. Cancer Science. 2024. doi:10.1111/cas.16245

BibTeX
@article{Fujikawa2024,
  author = {Fujikawa, Yoshiki and Kawabata, Shinji and Tsujino, Kohei and Yamada, Hironori and Kashiwagi, Hideki and Yagi, Ryokichi and Hiramatsu, Ryo and Nonoguchi, Naosuke and Takami, Toshihiro and Sasaki, Akinori and Hu, Naonori and Takata, Takushi and Tanaka, Hiroki and Suzuki, Minoru and Wanibuchi, Masahiko},
  title = {Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16245}
}
Kostenlos starten →